G. Brandon Gunn

The University of Texas MD Anderson Cancer Center

Papers

4

Total Citations

114

H-Index

3

About

G. Brandon Gunn is a leading head and neck surgeon whose research focuses on optimizing functional outcomes—particularly swallowing—in patients with oropharyngeal squamous cell carcinoma. His work directly compares the effectiveness of primary transoral robotic surgery (TORS) versus nonsurgical therapies like intensity-modulated proton therapy (IMPT). Gunn’s landmark 2019 study, cited 87 times, demonstrated that TORS with neck dissection can reduce the need for gastrostomy tubes and minimize weight loss compared to traditional chemoradiation, offering a personalized, less toxic treatment pathway for low- to intermediate-risk patients. He further showed that TORS patients experience less severe dysphagia over time, challenging the prevailing preference for nonsurgical approaches. By prospectively tracking swallowing function and toxicity, Gunn has provided critical evidence that surgical de-escalation can preserve quality of life without compromising oncologic control. His work has reshaped clinical decision-making, empowering patients and clinicians to choose treatments that prioritize both survival and everyday function. Gunn’s contributions are essential reading for any researcher or clinician striving to balance cure with compassion in head and neck oncology.

Research Focus

Key Achievements

3
H-Index
4
Papers
114
Total Citations
29
Avg Citations/Paper
🏆 Most Cited Paper
Dysphagia After Primary Transoral Robotic Surgery With Neck Dissection vs Nonsurgical Therapy in Patients With Low- to Intermediate-Risk Oropharyngeal Cancer
87 citations · 2019
📈 Most Prolific Year: 2019 (2 Papers)
🤝 Key Collaborators: 32
🏛 Institutions: The University of Texas MD Anderson Cancer Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago